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ABSTRACT Mice devoid of PrPC (Prnpo/o) are resistant to
scrapie and do not allow propagation of the infectious agent
(prion). PrPC-expressing neuroectodermal tissue grafted into
Prnpo/o brains but not the surrounding tissue consistently
exhibits scrapie-specific pathology and allows prion replica-
tion after inoculation. Scrapie prions administered intraocu-
larly into wild-type mice spread efficiently to the central
nervous system within 16 weeks. To determine whether PrPC
is required for scrapie spread, we inoculated prions intraocu-
larly into Prnpo/o mice containing a PrP-overexpressing neu-
rograft. Neither encephalopathy nor protease-resistant PrP
(PrPSc) were detected in the grafts for up to 66 weeks. Because
grafted PrP-expressing cells elicited an immune response that
might have interfered with prion spread, we generated Prnpo/o
mice immunotolerant to PrP and engrafted them with PrP-
producing neuroectodermal tissue. Again, intraocular inocu-
lation did not lead to disease in the PrP-producing graft.
These results demonstrate that PrP is necessary for prion
spread along neural pathways.
The infectious agent causing transmissible spongiform enceph-
alopathies such as sheep scrapie, bovine spongiform enceph-
alopathy, and experimental scrapie of mice and hamsters
seems to be devoid of informational nucleic acids (1–3) and
may consist entirely of protein (4). A large body of evidence
suggests that the prion is a modified form of the cellular
protein PrPC (5–7), perhaps identical to the protease-resistant
isoform termed PrPSc (but see ref. 8).
Intracerebral inoculation of tissue homogenate into suitable
recipients is the most effective method for transmission of
spongiform encephalopathies and frequently allows the spe-
cies barrier to be circumvented, albeit with reduced efficacy.
However, spongiform encephalopathies have also been trans-
mitted by feeding (9) as well as by intravenous, intraperitoneal
(10), and intramuscular injection (11). Prion diseases can also
be initiated from the eye by conjunctival instillation (12),
corneal grafts (13), and intraocular injection (14). The latter
method has proved particularly useful to study neural spread
of the agent, because the retina is a part of the central nervous
system (CNS) and intraocular injection does not disrupt the
blood–brain barrier or any other aspect of brain physiology.
The assumption that spread of prions occurs axonally rests
mainly on the demonstration of diachronic spongiform changes
along the retinal pathway after intraocular infection (14).
It has been repeatedly shown that expression of PrPC is
required for prion replication (15–18) and also for neurode-
generative changes to occur (19). We now set out to investigate
whether spread of prions within the CNS is also dependent on
PrPC. For the reasons mentioned above, the visual pathway
lends itself ideally to the study of this question. We trans-
planted embryonic neuroectoderm derived from midgestation
tg20 embryos overexpressing PrPC (20) into the caudoputamen
of Prnpo/o mice that are not susceptible to scrapie (15, 16, 21).
Such grafts grow and differentiate into neural, glial, and
endothelial components in a ratio similar to that observed in
adult brains (22). Intracerebral inoculation of scrapie prions
was shown earlier to invariably produce transmissible spongi-
form encephalopathy in the graft after 70 days but not in the
surrounding Prnpo/o tissue (19); therefore, neural grafts are
sensitive indicators of the presence of prion infectivity in the
brain of an otherwise scrapie-resistant host. The dependence
of prion spread on the presence of PrPC was then studied by
inoculating prions into the eye of a Prnpo/o mice carrying a tg20
graft (Fig. 1a).
EXPERIMENTAL PROCEDURES
Grafting Procedure. The neuroectodermal anlage of tg20
embryos (day 12.5 post conceptionem) was transplanted to the
caudoputamen of adult Prnpo/o or tg33 mice where it fully
differentiates into normal neuronal and glial components and
is integrated into the host brain (22). The tg20mouse line from
which grafts were derived carries multiple copies of a genomic
Prnp transgene and develops scrapie 63 6 2 days after intra-
cerebral inoculation with 7 log ID50 (in a total of 30 ml) of
Rocky Mountain Laboratory prions (20). tg33 mice overex-
press PrP on T cells and are scrapie-resistant (unpublished
results).
Inoculation. A 10% homogenate of pooled RML-infected
mouse brains (5 ml; 6.2 log ID50 units) was injected into the
eyeball of anesthetized mice 1, 25, 42, or 78 days after
transplantation. Early intraocular inoculation, 24 h after graft-
ing, was performed to minimize the probability of a neutral-
izing immune response to the PrP-expressing graft whichmight
reduce infectivity. The later time points were chosen to ensure
reconstitution of the blood–brain barrier, thereby minimizing
nonspecific leakage of infectivity to the indicator tissue. The
blood–brain barrier is largely reconstituted 60 days after
grafting, as shown by gadolinium-enhanced magnetic reso-
nance imaging (22).
Analysis of the Grafts. Mice were killed while under deep
anesthesia. For paraffin histology, whole mouse brains were
fixed for at least 24 h in 4% paraformaldehyde in PBS,
immersed for 1 h in 98% formic acid to reduce prion infectivity
(23), postfixed for 72 h in 4% paraformaldehydeyPBS, and
processed for paraffin embedding. Hematoxylin and eosin
staining and immunohistochemistry for GFAP (anti-GFAP
antiserum, 1:300; Dako), synaptophysin (SY antiserum 1:40;
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Dako), and PrP (anti-mouse PrP antiserum 1B3 1:300; ref. 24)
were all performed on sections of paraffin-embedded and
frozen tissue blocks. Biotinylated secondary antibodies (goat
anti-rabbit and rabbit-anti mouse, Dako) were used at a
1:200–1:300 dilution. Visualization was achieved using biotiny
avidin-peroxidase (Dako) and diaminobenzidine as a chromo-
gen following the protocols suggested by the manufacturer.
Histoblots were performed as described (19, 25). Frozen
brains cut in 12-mm-thick slices were mounted on nitrocellu-
lose membranes. Total PrP and, after digestion with 50 mgyml
proteinase K for 8 h at 558C, protease-resistant PrPSc were
detected with PrP antiserum 1B3 (1:5000 in 1% nonfat milk,
overnight at 48C) and alkaline phosphatase immunoconju-
gates. Visualization was performed using 5-bromo-4-chloro-
3-indolyl phosphate and 4-nitroblue tetrazolium chloride
(Boehringer Mannheim).
Detection of Humoral Immune Responses. Purified recom-
binant PrP (0.14 mg) and brain homogenate derived from
Prnpo/o (80 mg) and tg20mice (80 mg) were subjected to PAGE
and transferred to nitrocellulose membranes. They were then
incubated with whole mouse sera from mock- and scrapie-
inoculated grafted and control mice (diluted 1:100) and de-
veloped with a horseradish peroxidase-conjugated polyclonal
anti-mouse IgG antibody (1:2000).
RESULTS
In tg20 mice, unilateral intraocular inoculation led to progres-
sive appearance of scrapie pathology along the optic nerve and
optic tract to the contralateral superior colliculus and lateral
geniculate nucleus (Fig. 2 b–d) and was followed by general-
ized encephalopathy and death after 74–112 days. In agree-
ment with earlier studies (14, 26), these results suggest that the
infectious agent travels along fiber tracts of the CNS, such as
the retinotectal projection. After inoculation, Prnpo/o mice
grafted with tg20 tissue were killed after 222–467 days. By this
time, all intracerebrally infected grafts (n 5 17) developed
severe scrapie encephalopathy, including typical histopatho-
logical features (Fig. 1 g and h) and accumulation of protease-
resistant PrPSc (Fig. 2 c and d). The grafted region contained
at least 5.7 log ID50 of infectivity (19). In contrast, none of 7
mice inoculated intraocularly showed spongiosis, gliosis, syn-
aptic loss (Fig. 1 i and k), or PrPSc (Fig. 2 a and b). Identical
results were obtained with 5 mock-inoculated and 17 unin-
fected mice (Table 1). In one instance, the graft of an
intraocularly inoculated mouse was assayed and found to be
devoid of infectivity (Table 1). We conclude that infectivity
administered to the eye of PrP-deficient hosts cannot induce
scrapie in a PrP-expressing brain graft.
Engraftment of Prnpo/o mice with PrPC-producing tissue
might lead to an immune response to PrP (27) and possibly to
neutralization of infectivity. Indeed, analysis of sera from
grafted mice revealed significant anti-PrP antibody titers.
Because 1 of 2 mock-inoculated and 3 of 3 uninoculated
Prnpo/o mice showed an immune response to PrP 5–50 weeks
after neurografting, whereas nongrafted, intracerebrally inoc-
ulated Prnpo/o mice did not develop detectable antibody titers
(15), PrPC presented by the intracerebral graft rather than the
inoculum or graft-born PrPSc was the offending antigen. To
test whether grafts would develop scrapie if infectivity was
administered before establishment of an immune response, we
inoculated mice 24 h after grafting. Again, no disease was
detected in the graft of two mice inoculated intraocularly.
intracerebral infection with mouse prions. Spongiosis (g) and gliosis
(h) are conspicuous within the graft and were not observed in
uninoculated or mock-inoculated grafts (not shown). (i and k) Neural
grafts (tg20) 217 days after transplantation in a Prnpo/o host brain and
305 days after intraocular inoculation show no neuropathological
changes. The asterisks label the border between graft and host tissue.
FIG. 1. Neural grafts overexpressing PrPC in a Prnp-deficient host.
(a) Schematic drawing of the transplantation procedure. (b–d) Coro-
nal section of the thalamus of a PrP-overexpressing tg20mouse 78 days
after inoculation into the right eye. At time of analysis, the animal
showed clinical symptoms of scrapie. (b) Pronounced gliosis in the
visual pathway (optic tract and lateral geniculate nucleus, LGN) is
visualized by immunocytochemistry for glial fibrillary acid protein
(GFAP). (c and d) Asymmetric neurodegeneration of the LGN is
visualized by synaptophysin immunostain. The affected left LGN
displays coarse granular deposits and patchy staining that reflects
significant synaptic loss, whereas the unaffected right LGNdisplays the
fine granular synaptic stain typical of normal neural tissue. Because
scrapie infection starts in the visual system and is followed by
generalized disease in the CNS, the LGN and superior colliculus show
a more prominent astrocytic reaction and severe loss of neuronal
processes than other regions of the brain, e.g., the hippocampus. (e, g,
and i) Graft (gr) and adjacent host brain (h) in hematoxylin and eosin
stains. (f, h, and k) Immunohistochemical stain for GFAP. (e and f)
Neural graft (tg20) in a Prnpo/o host brain analyzed 232 days after
grafting without scrapie inoculation. Cellular density and distribution
of neurons and astrocytes within the graft are similar to that of normal
host brain. The slightly enhanced GFAP stain results from the
transplantation procedure. (g and h) Neural graft (tg20) in a Prnpo/o
host brain analyzed 231 days after grafting and 230 days after direct
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To definitively rule out the possibility that prion transport
was disabled by a neutralizing immune response, we repeated
the experiments in mice tolerant to PrP. We have generated
Prnpo/o mice transgenic for multiple copies of a hybrid gene
consisting of a PrP coding sequence under the control of the
lck promoter. These mice (designated tg33) overexpress PrP on
T lymphocytes but are resistant to scrapie and do not contain
scrapie infectivity in brain and spleen after inoculation with
scrapie prions (A.R., A.S., and C.W., unpublished results). tg33
mice engrafted with PrP-overexpressing tg20 neuroectoderm
did not develop antibodies to PrP after intracerebral or
intraocular inoculation (n 5 9) even 31 weeks after grafting,
presumably because of clonal deletion of PrP-immunoreactive
lymphocytes (Fig. 3). As before, intraocular inoculation with
prions did not provoke scrapie in the graft (n 5 5; data not
shown), supporting the conclusion that lack of PrPC, rather
than immune response to PrP, prevented spread.
DISCUSSION
Scrapie pathology and replication of infectivity after intraoc-
ular injection of wild-type mice occur along the anatomical
structures of the visual system (14) and spread to transsynaptic
structures such as the contralateral superior colliculus, lateral
geniculate nucleus, and visual cortex; this has been taken as
evidence for axonal transport of the agent. However, although
PrPC seems to travel with the fast axonal transport (28), the
very slow kinetics of disease development caused by prions, as
opposed to canonical neurotropic viruses (29), argues against
the hypothesis that prions follow fast or perhaps even slow
axonal transport. Because intraocular inoculation failed to
infect grafts even in the absence of an immune response to PrP,
PrPC appears to be necessary for the spread of prions along the
retinal projections and within the intact CNS. The prion itself
is therefore surprisingly sessile.
Because prion infectivity is consistently detectable earlier in
the spleen than in the brain, even after intracerebral inocula-
tion (26), it could be argued that prion replication in lym-
phoreticular organs may be involved in the neuroinvasiveness
of intraocular administered prions. Enucleation as late as 7
days after intraocular inoculation resulted in scrapie but
prevented targeting to the visual system (30), suggesting that
systemic infection and secondary neuroinvasion can bypass the
neural spread of prions if the visual pathway is interrupted
before prions colonize the brain through the retinotectal
projection. Therefore, the lack of graft infection described in
Table 1. Analysis of engrafted and control mice after intracerebral and intraocular inoculation
Genotype
Inoculum Site
Time of analysis,
days after
inoculation
Scrapie
pathologyHost Graft
Prnpoyo tg20 RML i.c. 222–467 17y17
Prnpoyo wt RML i.c. 147–245 3y3
Prnpoyo tg20 RML i.o. 147–293 0y5
Prnpoyo wt RML i.o. 238 0y2
Prnpoyo tg20 Mock- or not
inoculated
i.c. 250–473 0y20
Prnpoyo tg20 Mock- or not
inoculated
i.o. 266, 295 0y2
tg20 No graft RML i.c. 62–65 4y4
tg20 No graft RML i.o. 74,112 2y2
wt tg20 RML i.c. 104–148 10y10
wt tg20 RML i.o. 187–224 3y3*
tg33 tg20 RML i.c. 130–218 5y5
tg33 tg20 RML i.o. 130–218 0y5
Mice were engrafted and inoculated as described in the text. No Prnpoyo animal inoculated intraocularly and no animal either
inoculated with mock inoculum or left untreated developed spongiosis and gliosis (diagnosed by histological and immuno-
histochemical examination of paraffin sections) or showed accumulation of proteinase-resistant protein within the graft, as
determined by histoblot analysis (19, 25). The infectious titer of the graft of one intraocularly inoculated animal was determined
by injecting 20 ml of a 10% dilution prepared as described (19) intracerebrally into 2 tg20 indicator mice; no clinical or
histopathological signs of scrapie were found after 186 days (the incubation time at end-point dilution is about 110 days; ref.
20). i.c., Intracerebral; i.o., intraocular; wt, wild type.
*One animal analyzed 104 days after intraocular inoculation did not show graft pathology.
FIG. 2. Histoblot analysis of PrP expression. Frozen sections from
brains engrafted with PrP-overexpressing neuroectodermal tissue
weremounted on nitrocellulose, and PrP was displayed immunochemi-
cally without (a, c, and e) or with (b, d, and f) previous protease
digestion (25). Arrows pinpoint the position of grafts. Intracerebrally
infected grafts (c) consistently show stronger total PrP immunoreac-
tivity than uninfected (a) and intraocularly inoculated (e) grafts.
Protease-resistant PrP was formed only in intracerebrally infected
PrPC-expressing grafts (d) and migrated into the surrounding struc-
tures as described earlier (19). Uninfected (b) and intraocularly
inoculated (f) mice did not accumulate protease-resistant PrP (PrPSc).
As previously reported (19), myelinated structures show faint homo-
geneous background staining even in noninoculated Prnpo/o mice. no
inf., No infection; d, days; i.c., intracerebrally infected; i.o., intraocu-
larly inoculated.
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the present study suggests that the absence of extracerebral
PrPC impairs prion spread from extracerebral sites to the CNS,
in addition to blocking neural spread.
The present results indicate that intracerebral spread of
prions is based on a PrPC-paved chain of cells, perhaps because
they are capable of supporting prion replication. When such a
chain is interrupted by interposed cells that lack PrPC, as in the
case described here, no propagation of prions to the target
tissue can occur. Perhaps prions require PrPC for propagation
across synapses; PrPC is present in the synaptic region (31) and
certain synaptic properties are altered in Prnpo/o mice (32, 33).
It is also possible that transport of prions within (or on the
surface of) neuronal processes is PrPC-dependent. Within the
framework of the protein-only hypothesis (4, 6), these findings
may be accommodated by a ‘‘domino-stone’’ model in which
spreading of scrapie prions in the CNS occurs per continuitatem
through conversion of PrPC by adjacent PrPSc.
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